A new trading day began on Monday, with Clover Health Investments Corp (NASDAQ: CLOV) stock price up 5.59% from the previous day of trading, before settling in for the closing price of $3.04. CLOV’s price has ranged from $0.61 to $4.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 52.25% over the last five years. Meanwhile, its annual earnings per share averaged 73.31%. With a float of $376.94 million, this company’s outstanding shares have now reached $393.27 million.
The firm has a total of 552 workers. Let’s measure their productivity. In terms of profitability, gross margin is 33.96%, operating margin of -5.84%, and the pretax margin is -6.21%.
Clover Health Investments Corp (CLOV) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Healthcare Plans Industry. The insider ownership of Clover Health Investments Corp is 24.78%, while institutional ownership is 16.37%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 73.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Here are Clover Health Investments Corp’s current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Analysing the last 5-days average volume posted by the [Clover Health Investments Corp, CLOV], we can find that recorded value of 6.52 million was lower than the volume posted last year of 8.08 million. As of the previous 9 days, the stock’s Stochastic %D was 7.52%. Additionally, its Average True Range was 0.26.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 57.51%, which indicates a significant increase from 14.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.83% in the past 14 days, which was lower than the 96.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.54, while its 200-day Moving Average is $1.85. Now, the first resistance to watch is $3.30. This is followed by the second major resistance level at $3.38. The third major resistance level sits at $3.51. If the price goes on to break the first support level at $3.09, it is likely to go to the next support level at $2.96. Should the price break the second support level, the third support level stands at $2.88.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
With a market capitalization of 1.59 billion, the company has a total of 501,109K Shares Outstanding. Currently, annual sales are 2,034 M while annual income is -213,360 K. The company’s previous quarter sales were 330,990 K while its latest quarter income was -9,160 K.
